Ewing's sarcoma with distant metastasis: A brief note on management and emerging therapies

  • Girish Gulab Meshram | drgirish23@yahoo.co.in Department of Pharmacology, Postgraduate Institute of Medical Education and Research and Dr. Ram Manohar Lohia Hospital, New Delhi, India. http://orcid.org/0000-0003-1499-9970
  • Neeraj Kaur Department of Radiology, University of Texas Health Science Centre, San Antonio, Texas, United States.
  • Kanwaljeet Singh Hura Department of Pediatrics, Richmond University Medical Centre, Staten Island, New York, United States.


Ewing’s sarcoma is an aggressive fatal malignancy of bones and soft-tissue. It predominantly affects the young population, with a worldwide incidence of three cases per million. The pelvis, extremities, and ribs are the most common sites. We present a case of massive Ewing’s sarcoma of the right femur with metastasis to bones and lungs. The patient was treated with chemotherapy. However, he succumbed to his illness before completion of therapy. In conclusion, Ewing’s sarcoma with distant metastasis is a high risk case with poor prognosis. Integrating novel molecular targets with conventional chemotherapeutic agents holds a promise for high-risk Ewing’s sarcoma patients.

Google Scholar

Google Scholar



PlumX Metrics


Download data is not yet available.
Case Reports
Ewing's sarcoma, Distant metastasis, Chemotherapy
  • Abstract views: 644

  • PDF: 470
  • HTML: 27
How to Cite
Meshram, G. G., Kaur, N., & Hura, K. S. (2019). Ewing’s sarcoma with distant metastasis: A brief note on management and emerging therapies. Clinics and Practice, 9(3). https://doi.org/10.4081/cp.2019.1111